Streetbeat News

Products Services

REAX

The Real Brokerage has launched the Real Partners Program, aimed at helping agents expand their personal brand, strengthen client relationships, and achieve business objectives.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:41 am

LTRN

Lantern estimates that their drug LP-284 has the potential to improve outcomes for 40,000 to 80,000 patients with blood cancers annually, with a global annual market potential of $4 billion.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:40 am

ARAY

Accuray Incorporated (NASDAQ:ARAY) has received approval from the Chinese National Medical Products Administration for its Precision Treatment Planning System. This approval allows the system to be used with the CNNC-Accuray joint venture Tomo® C radiation therapy system, expanding cancer care options in China.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:39 am

DNNGY

TSLA

Orsted (OTC:DNNGY) is investing in a Tesla (NASDAQ:TSLA) battery energy storage system to stabilize the U.K. energy supply and reduce price volatility. The system will be installed at the Hornsea 3 Offshore Wind Farm and is expected to be operational by the end of 2026.

Portfolio Pulse from Lekha Gupta

June 12, 2024 | 11:38 am

AAPL

BIDU

Apple Inc. (NASDAQ:AAPL) is working to introduce its AI technology, Apple Intelligence, in China despite stringent regulations. Craig Federighi, Apple's senior VP of software engineering, acknowledged the challenges but confirmed the company's efforts. This move is crucial as China is Apple's second-largest market, and the company faces fierce competition from local companies. Rivals like Samsung and Lenovo have teamed up with Baidu Inc. (NASDAQ:BIDU) to offer AI-powered features in China.

Portfolio Pulse from Rounak Jain

June 12, 2024 | 11:38 am

LTRN

Lantern Pharma announced that the Japan Patent Office has issued a certificate of patent for the composition of matter covering their drug candidate LP-284.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:34 am

PTN

Palatin Technologies has initiated a Phase 2 trial to evaluate the combined efficacy of bremelanotide and tirzepatide in managing obesity. Topline data is expected by the end of 2024, with additional studies being considered for other metabolic conditions.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:34 am

BTCUSD

Billionaire investor Bill Miller believes Bitcoin remains significantly undervalued despite its recent performance against fiat currencies. He highlights Bitcoin's potential as a superior monetary governance system free from human intervention and manipulation.

Portfolio Pulse from Murtuza Merchant

June 12, 2024 | 11:32 am

LIND

Lindblad Expeditions Holdings, Inc. (NASDAQ:LIND) has expanded its operations in the Galápagos market by adding two new purpose-built expedition vessels to its fleet. Financial terms of the addition were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:32 am

LASE

Laser Photonics has launched its new Sabertech Laser Cutting Systems, expanding its product lines which already include laser cleaning, welding, marking, and engraving systems.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2024 | 11:21 am